• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康受试者在5天口服给药期间青蒿琥酯不存在时间依赖性药代动力学。

Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.

作者信息

Diem Thuy L T, Ngoc Hung L, Danh P T, Na-Bangchang K

机构信息

Faculty of Allied Health Sciences, Pharmacology and Toxicology Unit, Graduate Program in Biomedical Sciences, Thammasat University, Rangsit Campus, Pathumthani, Thailand.

出版信息

Eur J Clin Pharmacol. 2008 Oct;64(10):993-8. doi: 10.1007/s00228-008-0506-6. Epub 2008 Jul 4.

DOI:10.1007/s00228-008-0506-6
PMID:18600318
Abstract

AIM

The aim of the present study was to investigate the existence of time-dependent pharmacokinetics of artesunate (ARS) during 5 consecutive days of oral administration to 10 healthy Vietnamese subjects (aged 21-52 years and weighing 49-90 kg).

METHODS

Each volunteer received 200 mg oral doses of ARS once daily for 5 consecutive days. Blood samples (3 ml each) were collected on days 1 and 5 at 0 (before dosing), 0.5, 1, 2, 3, 4, and 6 h after drug administration. During days 2, 3, and 4, the same volumes of blood were collected at 0, 1, 2, and 4 h after dosing. Plasma ARS and dihydroartemisinin (DHA) were measured using high-performance liquid chromatography-mass spectrometry (LC-MS).

RESULTS

Results did not show evidence of time-dependency for ARS or the active plasma metabolite DHA. There were no differences in the concentrations of ARS and DHA at all sampling times on days 1 and 5. In addition, the pharmacokinetics of both compounds were similar on days 1 and 5. This finding confirms that the enzyme auto-induction in drug metabolism may not be characteristic of the endoperoxide sesquiterpene antimalarial group.

摘要

目的

本研究旨在调查10名健康越南受试者(年龄21 - 52岁,体重49 - 90 kg)连续5天口服青蒿琥酯(ARS)期间是否存在时间依赖性药代动力学。

方法

每位志愿者连续5天每天口服200 mg的ARS。在第1天和第5天给药后0(给药前)、0.5、1、2、3、4和6小时采集血样(每次3 ml)。在第2、3和4天,给药后0、1、2和4小时采集相同体积的血液。使用高效液相色谱 - 质谱联用仪(LC - MS)测定血浆中的ARS和双氢青蒿素(DHA)。

结果

结果未显示ARS或活性血浆代谢物DHA存在时间依赖性的证据。第1天和第5天所有采样时间点的ARS和DHA浓度均无差异。此外,两种化合物在第1天和第5天的药代动力学相似。这一发现证实药物代谢中的酶自诱导可能不是内过氧化物倍半萜抗疟药组的特征。

相似文献

1
Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration.健康受试者在5天口服给药期间青蒿琥酯不存在时间依赖性药代动力学。
Eur J Clin Pharmacol. 2008 Oct;64(10):993-8. doi: 10.1007/s00228-008-0506-6. Epub 2008 Jul 4.
2
The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.蒿甲醚、青蒿琥酯及其代谢产物二氢青蒿素在大鼠体内的多剂量药代动力学
Xenobiotica. 2011 Mar;41(3):252-8. doi: 10.3109/00498254.2010.542257. Epub 2010 Dec 22.
3
Development and validation of a liquid chromatography-mass spectrometry method for the simultaneous quantification of artesunate and dihydroartemisinin in human plasma.一种用于同时定量人血浆中青蒿琥酯和双氢青蒿素的液相色谱-质谱法的开发与验证
Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):963-77.
4
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.青蒿琥酯和双氢青蒿素在转移性乳腺癌患者长期口服青蒿琥酯期间的群体药代动力学。
Eur J Clin Pharmacol. 2014 Dec;70(12):1453-63. doi: 10.1007/s00228-014-1754-2. Epub 2014 Sep 25.
5
Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.青蒿琥酯与青蒿素在健康志愿者体内相互作用的多剂量研究。
Br J Clin Pharmacol. 2001 Oct;52(4):377-85. doi: 10.1046/j.0306-5251.2001.01461.x.
6
An investigation of the auto-induction of and gender-related variability in the pharmacokinetics of dihydroartemisinin in the rat.在大鼠中二氢青蒿素药代动力学的自身诱导作用及性别相关变异性的研究。
Malar J. 2012 Nov 21;11:379. doi: 10.1186/1475-2875-11-379.
7
The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.青蒿琥酯-哌喹固定复方口服给药后,尿苷二磷酸葡萄糖醛酸转移酶(UGTs)基因多态性对健康中国受试者中双氢青蒿素自诱导II相代谢介导的药代动力学的影响。
Malar J. 2014 Dec 4;13:478. doi: 10.1186/1475-2875-13-478.
8
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects.健康受试者单次和多次口服青蒿琥酯后青蒿琥酯和双氢青蒿素的群体药代动力学。
Malar J. 2009 Dec 18;8:304. doi: 10.1186/1475-2875-8-304.
9
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.青蒿琥酯/双氢青蒿素在妊娠急性疟疾中的药代动力学:吸收、生物利用度、分布和疾病影响。
Br J Clin Pharmacol. 2012 Mar;73(3):467-77. doi: 10.1111/j.1365-2125.2011.04103.x.
10
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.综述了静脉、肌肉、口服和直肠给药后青蒿琥酯及其活性代谢物双氢青蒿素的临床药代动力学。
Malar J. 2011 Sep 13;10:263. doi: 10.1186/1475-2875-10-263.

引用本文的文献

1
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.肯尼亚女性阴道内自行给药青蒿琥酯阴道栓的药代动力学I期研究。
PLoS One. 2025 Apr 9;20(4):e0316334. doi: 10.1371/journal.pone.0316334. eCollection 2025.
2
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.肯尼亚女性使用自行给药的青蒿琥酯阴道栓的药代动力学I期研究。
medRxiv. 2025 Feb 19:2024.07.08.24309596. doi: 10.1101/2024.07.08.24309596.
3
Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating malaria in the central highlands of Vietnam.

本文引用的文献

1
Development and validation of a liquid chromatography-mass spectrometry method for the simultaneous quantification of artesunate and dihydroartemisinin in human plasma.一种用于同时定量人血浆中青蒿琥酯和双氢青蒿素的液相色谱-质谱法的开发与验证
Southeast Asian J Trop Med Public Health. 2008 Nov;39(6):963-77.
2
Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria.五日口服双氢青蒿素单药疗法治疗非复杂性恶性疟患者的药代动力学
Drug Metab Pharmacokinet. 2008;23(3):158-64. doi: 10.2133/dmpk.23.158.
3
A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens.
吡喹酮-青蒿琥酯(派姆)治疗越南北部高原疟疾的疗效。
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0004424. doi: 10.1128/aac.00044-24. Epub 2024 Jul 24.
4
Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?将青蒿素及其衍生物重新用作抗癌药物:机遇还是挑战?
Front Pharmacol. 2021 Dec 31;12:828856. doi: 10.3389/fphar.2021.828856. eCollection 2021.
5
Pyronaridine-Artesunate (Pyramax) for Treatment of Artemisinin- and Piperaquine-Resistant Plasmodium falciparum in the Central Highlands of Vietnam.吡喹酮-青蒿琥酯(派姆瓦)治疗越南北部中央高地耐青蒿素和哌喹的恶性疟原虫。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0027621. doi: 10.1128/AAC.00276-21. Epub 2021 Sep 27.
6
Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.越南中南部宁顺省福川乡恶性疟原虫对青蒿素类药物的敏感性和间日疟原虫对氯喹的敏感性。
Malar J. 2019 Jan 17;18(1):10. doi: 10.1186/s12936-019-2640-2.
7
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia.东南亚青蒿素耐药性的群体药代动力学和药效学建模。
AAPS J. 2017 Nov;19(6):1842-1854. doi: 10.1208/s12248-017-0141-1. Epub 2017 Sep 11.
8
The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.青蒿琥酯-哌喹固定复方口服给药后,尿苷二磷酸葡萄糖醛酸转移酶(UGTs)基因多态性对健康中国受试者中双氢青蒿素自诱导II相代谢介导的药代动力学的影响。
Malar J. 2014 Dec 4;13:478. doi: 10.1186/1475-2875-13-478.
9
Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.青蒿琥酯和双氢青蒿素在转移性乳腺癌患者长期口服青蒿琥酯期间的群体药代动力学。
Eur J Clin Pharmacol. 2014 Dec;70(12):1453-63. doi: 10.1007/s00228-014-1754-2. Epub 2014 Sep 25.
10
Antimalarial activity of the myxobacterial macrolide chlorotonil a.粘细菌大环内酯类化合物氯托尼尔A的抗疟活性
Antimicrob Agents Chemother. 2014 Nov;58(11):6378-84. doi: 10.1128/AAC.03326-14. Epub 2014 Aug 11.
基于模型评估青蒿素类抗疟药对CYP2B6和CYP2C19的诱导特性:对联合用药方案的影响。
J Pharmacokinet Pharmacodyn. 2008 Apr;35(2):203-17. doi: 10.1007/s10928-008-9084-6. Epub 2008 Mar 19.
4
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!以青蒿素为基础的联合疗法(ACTs):疟疾治疗的最大希望,但贫困人群难以获得!
Acta Trop. 2005 Sep;95(3):305-15. doi: 10.1016/j.actatropica.2005.06.009.
5
The pharmacokinetics of oral dihydroartemisinin and artesunate in healthy Thai volunteers.健康泰国志愿者口服双氢青蒿素和青蒿琥酯的药代动力学
Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):575-82.
6
Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases.双氢青蒿素在体内以及人肝微粒体和表达的尿苷二磷酸葡萄糖醛酸基转移酶作用下的葡萄糖醛酸化反应。
Drug Metab Dispos. 2002 Sep;30(9):1005-12. doi: 10.1124/dmd.30.9.1005.
7
Pharmacokinetics of artesunate after single oral administration to rats.青蒿琥酯单次口服给予大鼠后的药代动力学
BMC Pharmacol. 2001;1:12. doi: 10.1186/1471-2210-1-12. Epub 2001 Dec 20.
8
Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.鉴定参与青蒿素体外代谢的人细胞色素P450酶。
Br J Clin Pharmacol. 1999 Oct;48(4):528-35. doi: 10.1046/j.1365-2125.1999.00044.x.
9
Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.用青蒿琥酯口服治疗恶性疟5天期间,血浆中双氢青蒿素浓度下降。
Antimicrob Agents Chemother. 1999 Mar;43(3):690-2. doi: 10.1128/AAC.43.3.690.
10
Artemisinin induces omeprazole metabolism in human beings.青蒿素可诱导人体中奥美拉唑的代谢。
Clin Pharmacol Ther. 1998 Aug;64(2):160-7. doi: 10.1016/S0009-9236(98)90149-7.